MicrobiologybioRxiv
An engineered receptor-binding domain improves the immunogenicity of multivalent SARS-CoV-2 vaccines
B. D. Quinlan, W. Li, H. Mou…·M. Farzan
This paper shows that an engineered RBD with glycosylation sites improves immunogenicity and expression efficiency in SARS-CoV-2 vaccines.
DOI 10.1128/mbio.00930-21